Li, Lu

Updated results of a phase I, open-label study of BCMA/CD19 dual-targeting fast CAR-T GC012F for patients with relapsed/refractory multiple myeloma (RRMM).

Du, J., Fu, W.-J., Jiang, H., Dong, B., Gao, L., Liu, L., Ge, J., He, A., Li, L., Lu, J., et al. (2023) · Journal of Clinical Oncology

CAR-T cell therapy researchMultiple Myeloma Research and Treatments

Cited by 35

Improved Algal Sludge Methane Production and Dewaterability by Zerovalent Iron-Assisted Fermentation

Geng, S., Song, K., Li, L., & Xie, F. (2020) · ACS Omega

Anaerobic Digestion and Biogas ProductionMicrobial Fuel Cells and Bioremediation

Cited by 16